A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Treatment of Subjects With Asthma
Phase of Trial: Phase IV
Latest Information Update: 14 Dec 2016
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Mar 2010 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 23 Feb 2010 Actual patient number (628) added as reported by ClinicalTrials.gov.